Department of Chemistry, Binghamton University, The State University of New York, Binghamton, New York 13902, United States.
ACS Chem Biol. 2023 Jan 20;18(1):7-11. doi: 10.1021/acschembio.2c00769. Epub 2022 Dec 29.
RNA interference (RNAi) is a well-established research tool and is also maturing as a novel therapeutic approach. For the latter, microRNA-like off-target activity of short interfering RNAs (siRNAs) remains as one of the main problems limiting RNAi drug development. In this communication, we report that replacement of a single internucleoside phosphodiester in the seed region (nucleotides 2 to 7) of the guide strand with an amide linkage suppressed the undesired microRNA-like off-target activity by at least an order of magnitude. For the specific siRNA targeting the PIK3CB gene, an amide modification between the third and fourth nucleotides of the guide strand showed the strongest enhancement of specificity (completely eliminated off-target silencing) while maintaining high on-target activity. These results are important because off-target activity is one of the main remaining roadblocks for RNA based drug development.
RNA 干扰 (RNAi) 是一种成熟的研究工具,也正在发展成为一种新的治疗方法。对于后者,短干扰 RNA (siRNA) 的类似 microRNA 的脱靶活性仍然是限制 RNAi 药物开发的主要问题之一。在本通讯中,我们报告说,在向导链的种子区域(核苷酸 2 到 7)中用酰胺键替代单个核苷内磷酸二酯键,至少可以将不需要的类似 microRNA 的脱靶活性降低一个数量级。对于针对 PIK3CB 基因的特定 siRNA,向导链的第三和第四个核苷酸之间的酰胺修饰显示出最强的特异性增强(完全消除脱靶沉默),同时保持高靶标活性。这些结果很重要,因为脱靶活性是 RNA 药物开发的主要遗留障碍之一。